Uruguay-based biotech Eolo Pharma raised a US$2.7m Series A from CITES and a group of international investors to fund preclinical trials for an obesity treatment. Eolo Pharma is run by…
-
-
Carao Ventures led a US$2m follow-on investment in Speratum, a Costa Rican biotech focused on microRNA-directed oncology therapies primarily for pancreatic and ovarian cancers. Carao previously invested US$800k when Speratum…
-
KaszeK Ventures and SOS Ventures made a US$3m investment in NotCo, a Chilean foodtech startup accelerated at IndieBio. NotCo uses plant-based proteins to replicate mayonnaise, milk and other animal-based products without any animal-derived ingredients.
-
Austral Capital is raising a third fund, the Latin America Growth Tech Fund, with a US$80m target. Fund 1 (2008) was a US$40m tech/biotech-focused fund whose portfolio includes Andes Biotechnologies and Scanntech. Fund II (2012) was a US$20m renewable energy-focused fund.
-
Brazil’s BNDES selected DOMO Invest to manage its angel co-investment fund, which will invest up to R$100m over the next ten years across sectors, with initial tickets up to R$500k.
-
Y Combinator’s Winter 2018 cohort includes Runa HR, an automated payroll platform in Mexico, Ropeo, a Colombian on-demand fashion service, Flint, a mobile wallet operating in Mexico, Qulture.rocks, a Brazilian…
-
SP Ventures exited Bug Agentes Biológicos, a Brazilian biotech firm, though a sale to Dutch biochemical company Koppert Biological Systems. (Valor Econômico) A holandesa Koppert fechou a aquisição, por meio…
-
Fondo Alerce made a US$1.4m investment in GeneproDX SPA, a Chilean biomedical startup working on thyroid cancer detection. (LexLatin) La empresa chilena de biomedicina GeneproDX SPA recibió un aporte de…
-
Tim Draper and Cygnus capital have partnered to launch the Draper Cygnus VC Fund to invest in Argentinian startups. (La Nacion) Tim Draper, que invirtió en 30 proyectos que se…
-
OneSkin is a biotech startup in Silicon Valley with ambitious plans to discover anti-aging molecules. In LAVCA’s interview with Brazilian founder and CEO Carolina Reis, and Colombian CTO Andrés Ochoa, we learn: How they translated their academic roots in biochemistry and genomics in Brazil into startup technology…